1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
EPS Bio Technology Corp.

EPS Bio Technology Corp.

4183.TWO
EPS Bio Technology Corp.TW flagTaipei Exchange
14.00
TWD
- -
- -
333.20MMarket Cap
EPS Bio Technology Corp.
4183.TWO
(Taipei Exchange)

Recent

price

14.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
15.79
18.37
17.21
18.46
15.57
20.42
22.45
18.05
17.4
19.3
20.07
20.18
19.47
19.75
18.95
- -
19.66
Revenue per Share
0.65
1.02
0.64
0.46
-1.58
1.77
1.4
0.12
0.66
0.77
1.33
0.78
1.07
0.88
0.73
- -
-0.6
Basic EPS, GAAP
-1.36
1.34
0.13
1.4
-0.97
2.34
1.63
1.25
-0.14
0.2
3.06
0.84
-0.42
1.92
-1.96
- -
-1.15
Free Cash Flow per Basic Share
- -
- -
0.81
0.58
0.1
- -
0.4
0.82
0.3
0.7
0.7
1.2
0.7
0.98
0.8
- -
- -
Dividend per Share
9.76
- -
10.9
10.15
8.42
10.45
11.41
10.67
10.78
10.79
11.35
10.8
11.1
10.89
10.74
- -
9.47
Book Value per Share
8.43
- -
10.64
9.28
7.87
9.86
11.05
11.75
11.96
12.02
12.7
12.35
12.8
12.78
12.72
- -
11.52
Tangible Book Value per Share
17
17
20
21
21
21
21
23
24
24
24
24
24
24
24
- -
24
Basic Weighted Avg Shares
275
321
339
384
324
425
467
420
414
459
478
480
463
470
451
500
469
Sales/Revenue/Turnover
2.45
6.08
5.48
1.89
-13.13
9.1
8.22
4.14
2.41
5.87
9.52
7.13
4.02
5.33
0.78
-1.3
-1.28
Operating Margin (%)
14
16
16
19
22
20
14
14
15
16
18
19
17
15
15
15
14
Depreciation Expense
11
18
13
9
-33
37
29
3
16
18
32
19
25
21
17
-8
-14
Net Income, GAAP
- -
3.22
15.87
16.98
- -
13.53
17.05
48.67
11.29
23.21
20.89
20.76
7.64
20.67
2.8
- -
20.41
Effective Tax Rate (%)
4.14
5.56
3.74
2.47
-10.13
8.68
6.21
0.65
3.81
4.01
6.64
3.88
5.47
4.46
3.84
-1.57
-3.03
Profit Margin (%)
95
- -
151
140
113
164
187
223
231
224
244
236
244
241
238
201
198
Working Capital
54
- -
43
37
40
34
30
28
26
132
126
121
116
110
104
95
98
LT Debt
170
- -
223
220
186
222
243
284
292
294
309
299
308
306
305
281
277
Total Equity
- -
11.53
11.51
2.21
- -
12.99
11.65
2.99
2.77
5.48
8.15
6.14
3.95
4.6
0.81
- -
6.74
Return on Invested Capital (%)
- -
12.03
10.47
3.98
- -
15.28
11.25
1.12
5.79
6.03
8.45
5.19
7.11
5.96
5.21
- -
8.18
Return on Capital (%)
- -
21.01
11.81
4.45
-16.99
18.79
12.76
1.12
6.26
7.18
12.04
7.07
9.73
8.02
6.72
-3.24
-5.88
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
6
6
6
LT Borrowings
10
10
9
LT Finance Leases
94
90
89
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
24
24
24
Market Capitalization
550
547
473

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
368
373
365
Cash, Cash Equivalents & STI
129
126
120
Accounts Receivable, Net
150
149
137
Inventories
81
88
97
Total Current Liabilities
130
142
167
Payables & Accruals
- -
- -
- -
ST Debt
6
6
6
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.57%
-1.82%
-7.7%
Free Cash Flow
1.69%
-206.78%
-50.02%
Net Income, GAAP
27.13%
-37.07%
-145.45%
Sales/Revenue/Turnover
1.86%
1.05%
10.78%
Total Cash Common Dividend
- -
7.03%
-16.25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
91
112
116
151
470
2024
98
134
103
117
451
2025
120
130
119
- -
500

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.1
0.18
0.43
- -
0.88
2024
0.5
0.34
0.27
- -
0.73
2025
0.05
-0.54
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.98
2024
- -
- -
- -
- -
0.8
2025
- -
- -
- -
- -
- -
Similar Companies
AnteoTech Limited (ADO.AX)
Embla Medical hf. (EMBLA.CO)
Sincere Co. Ltd. (7782.T)
Assure Tech (Hangzhou) Co., Ltd. (688075.SS)
908 Devices Inc. (MASS)
Lancer Orthodontics, Inc. (LANZ)
Business
EPS Bio Technology Corp. manufactures and sells original equipment manufacturer and original design manufacturer blood glucose monitoring systems in Taiwan. The company offers diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE brands; test strips; and wearable blood glucose monitors with NFC and Bluetooth connectivity. Founded in 2006 and headquartered in Hsinchu Science Park, Hsinchu City, Taiwan, EPS Bio Technology operates primarily in the medical devices sector, serving diabetes management markets with a workforce of approximately 116 employees focused on research and development.